Ledger.Open graph →
SEC Form D · filed July 30, 2024

Brenig Therapeutics, Inc

Offering
$65.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DOVER, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Michele Cucullu · Dover, DEDirectorKeno Gutierrez · Seattle, WADirectorIain Dukes · New York, NYExec · DirectorEdward Mathers · Boston, MADirectorNikolay Savchuk · Newtown, PAExec · DirectorKeno Gutierrez · Dover, DEDirectorIain Dukes · New York, NYExec · DirectorEdward Mathers · Cambridge, MADirectorNikolay Savchuk · Newtown, PAExec · DirectorMichele Cucullu · Dover, DEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗